General

Highly Pathogenic Avian Influenza Identified in New-Mexico for Veterinerians

Highly Pathogenic Avian Influenza identified in New Mexico Cattle and Texas Resident

MPOX cases have declined in the United States since the peak of the outbreak in mid-August

On February 28, 2024, the Centers for Disease Control and Prevention (CDC) endorsed the Advisory Committee on Immunization Practices (ACIP) recommendation for adults aged 65 years and older to receive an additional dose of the updated 2023-2024 COVID-19 vaccine.

The New Mexico Department of Health (NMDOH) is notifying healthcare providers that there is an increasing incidence of measles in the United States and in other countries.

Healthcare providers in New Mexico can improve coverage with lifesaving vaccines and antivirals for influenza this season. Influenza vaccination coverage among adults ≥65 years old in New Mexico has increased between the previous two seasons, but at 63% this high-risk population remains below the full population Healthy People 2030 target of 70%.

Immunization Coverage for Influenza, COVID-19 and Use of Authorized/Approved Therapeutics

CDC Advisory - High Blood Lead Levels in Children Consuming Recalled Cinnamon

Protecting Infants from RSV during the National Nirsevimab (Beyfortus) Shortage

New Mexico Department of Health Announces Start of Influenza (Flu) Season

Increase in firearm related morbidity and mortality in New Mexico: Recommendations for preventing firearm injury, homicide and suicide

The New Mexico Department of Health (NMDOH) is investigating a statewide outbreak of Cryptosporidiosis associated with exposure to petting zoo livestock at the New Mexico State Fair, which took place from September 7-17th, 2023. There have been 3 patients with laboratory-confirmed Cryptosporidiosis infections and an additional 15 clinically compatible cases who report exposure to the NM State Fair. Cases reside in multiple counties across the state.

New Mexico Department of Health Seeks Clinician Enrollment in ILINet

On September 11, 2023, the FDA approved the 2023-2024 formulation of both the Moderna COVID-19 and the Pfizer-BioNTech COVID-19 vaccines for everyone 6 months of age and older. The Advisory Committee on Immunization Practices (ACIP) voted on September 12, 2023, to recommend the updated vaccines and the CDC endorsed the ACIP recommendations the same day.

Doxycycline Post-Exposure Prophylaxis (doxy-PEP) for the Prevention of Sexually Transmitted Infections

Increased Numbers of West Nile Cases in New Mexico in 2023 - August 18, 2023

As the number of COVID-19 cases rises across the US, the New Mexico Department of Health recommends that providers prescribe Paxlovid (nirmatrelvir/ritonavir) to all appropriate patients diagnosed with COVID-19. Paxlovid, an oral antiviral, is a highly effective treatment for COVID-19 but continues to be under prescribed by providers1. Support for the use of Paxlovid comes from several randomized trials and observational studies of symptomatic outpatients with COVID-19, which demonstrated a reduction in hospitalization and death.

New HIV infections associated with former VIP Spa in Albuquerque - June 26, 2023

The New Mexico Department of Health has identified five cases of Hantavirus Pulmonary Syndrome (HPS) in New Mexico residents in the first five months of 2023, already exceeding the average annual case count.

Updated SARS-CoV-2/COVID-19 Test Result Reporting Instructions